Dhruva Rao Pawan Kumar, Peiris Sooriyaratchige Pradeep Manjula, Arif Seema Safia, Davies Rhodri A, Masoud Ashraf Gergies, Haray Puthucode Narayanan
Pawan Kumar Dhruva Rao, Sooriyaratchige Pradeep Manjula Peiris, Seema Safia Arif, Rhodri A Davies, Ashraf Gergies Masoud, Puthucode Narayanan Haray, Department of Colorectal Surgery, Prince Charles Hospital, Merthyr Tydfil CF47 9DT, United Kingdom.
World J Gastrointest Surg. 2017 Jun 27;9(6):153-160. doi: 10.4240/wjgs.v9.i6.153.
To assess the impact of multi-disciplinary teams (MDTs) management in optimising the outcome for rectal cancers.
We undertook a retrospective review of a prospectively maintained database of patients with rectal cancers (defined as tumours ≤ 15 cm from anal verge) discussed at our MDT between Jan 2008 and Jan 2011. The data was validated against the national database to ensure completeness of dataset. The clinical course and follow-up data was validated using the institution's electronic patient records. The data was analysed in terms of frequencies and percentages. Significance of any differences were analysed using χ test. A Kaplan-Meier analysis was performed for overall survival and disease free survival.
Following appropriate staging, one hundred and thirty-three patients were suitable for potentially curative resections. Seventy two (54%) were upper rectal cancer (URC) - tumour was > 6 cm from the anal verge and 61 (46%) were lower rectal cancers (LRC) - lower extent of the tumour was palpable ≤ 6 cm. Circumferential resection margin (CRM) appeared threatened on pre-operative MRI in 19/61 (31%) patients with LRC requiring neo-adjuvant therapy (NAT). Of the 133 resections, 118 (89%) were attempted laparoscopically (5% conversion rate). CRM was positive in 9 (6.7%) patients; Median lymph node harvest was 12 (2-37). Major complications occurred in 8 (6%) patients. Median follow-up was 53 mo (0-82). The 90-d mortality was 2 (1.5%). Over the follow-up period, disease related mortality was 11 (8.2%) and overall mortality was 39 (29.3%). Four (3%) patients had local recurrence and 22 (16.5%) patients had distant metastases.
Management of rectal cancers can be optimized with multi-disciplinary input to attain acceptable long-term oncological outcomes even when incorporating a laparoscopic approach to rectal cancer resection.
评估多学科团队(MDT)管理对优化直肠癌治疗效果的影响。
我们对2008年1月至2011年1月在我院多学科团队讨论的直肠癌患者(定义为距肛缘≤15 cm的肿瘤)前瞻性维护数据库进行了回顾性分析。数据与国家数据库进行了验证,以确保数据集的完整性。临床病程和随访数据使用该机构的电子病历进行了验证。数据按频率和百分比进行分析。使用χ检验分析任何差异的显著性。对总生存期和无病生存期进行了Kaplan-Meier分析。
经过适当分期后,133例患者适合进行潜在的根治性切除。72例(54%)为上段直肠癌(URC)——肿瘤距肛缘>6 cm,61例(46%)为下段直肠癌(LRC)——肿瘤下缘可触及≤6 cm。在61例需要新辅助治疗(NAT)的LRC患者中,19例(31%)术前MRI显示环周切缘(CRM)受到威胁。在133例切除术中,118例(89%)尝试了腹腔镜手术(转化率为5%)。9例(6.7%)患者CRM阳性;中位淋巴结清扫数为12个(2 - 37个)。8例(6%)患者发生了主要并发症。中位随访时间为53个月(0 - 82个月)。90天死亡率为2例(1.5%)。在随访期间,疾病相关死亡率为11例(8.2%),总死亡率为39例(29.3%)。4例(3%)患者出现局部复发,22例(16.5%)患者出现远处转移。
即使采用腹腔镜直肠癌切除术,多学科协作也可优化直肠癌的治疗,以获得可接受的长期肿瘤学结局。